Richard M. Ruedy Net Worth

The estimated Net Worth of Richard Ruedy is at least $10.6 Milion dollars as of 5 March 2024. Mr Ruedy owns over 3,800 units of Silk Road Medical Inc stock worth over $5,603,568 and over the last 6 years he sold SILK stock worth over $4,568,892. In addition, he makes $433,059 as Exec. VP of Clinical i Regulatory Affairs & Quality Assurance at Silk Road Medical Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr Ruedy SILK stock SEC Form 4 insiders trading

Mr has made over 11 trades of the Silk Road Medical Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he sold 3,800 units of SILK stock worth $65,246 on 5 March 2024.

The largest trade he's ever made was exercising 108,974 units of Silk Road Medical Inc stock on 23 November 2020 worth over $171,089. On average, Mr trades about 17,977 units every 110 days since 2019. As of 5 March 2024 he still owns at least 205,711 units of Silk Road Medical Inc stock.

You can see the complete history of Mr Ruedy stock trades at the bottom of the page.

Mr. Richard M. Ruedy biography

Richard M. Ruedy is the Exec. VP of Clinical, Regulatory Affairs & Quality Assurance at Silk Road Medical Inc.

What is the salary of Mr Ruedy?

As the Exec. VP of Clinical i Regulatory Affairs & Quality Assurance of Silk Road Medical Inc, the total compensation of Mr Ruedy at Silk Road Medical Inc is $433,059. There are 6 executives at Silk Road Medical Inc getting paid more, with Erica Rogers having the highest compensation of $3,679,060.

How old is Mr Ruedy?

Mr Ruedy is 54, he's been the Exec. VP of Clinical i Regulatory Affairs & Quality Assurance of Silk Road Medical Inc since . There are 6 older and 7 younger executives at Silk Road Medical Inc. The oldest executive at Silk Road Medical Inc is Jack Lasersohn, 66, who is the Independent Director.

What's Mr Ruedy's mailing address?

Richard's mailing address filed with the SEC is C/O SILK ROAD MEDICAL, INC., 1213 INNSBRUCK DRIVE, SUNNYVALE, CA, 94089.

Insiders trading at Silk Road Medical Inc

Over the last 6 years, insiders at Silk Road Medical Inc have traded over $925,682,871 worth of Silk Road Medical Inc stock and bought 14,200 units worth $302,033 . The most active insiders traders include X Finance, L.P.Wpx Gp, L.P...., Pincus & Co.Kaye Charles R ... oraz Pincus & Co.Warburg Pincus .... On average, Silk Road Medical Inc executives and independent directors trade stock every 12 days with the average trade being worth of $4,280,712. The most recent stock trade was executed by Kevin M Klemz on 19 August 2024, trading 2,268 units of SILK stock currently worth $61,463.

What does Silk Road Medical Inc do?

silk road medical, inc. is a privately held company located in sunnyvale, california, dedicated to preventing the devastating burden of stroke through surgical innovation. the company develops and manufactures less-invasive medical devices to improve the treatment of vascular disease through proprietary transcarotid therapies. by innovating around proven surgical principles and developing breakthrough technology for vascular specialists, we can improve the lives of people with carotid artery disease. our history is one of deep collaboration with vascular specialists and our future will be guided by continuous learning, observation and improvement. for more information on the company, visit our website at http://silkroadmed.com/. the transcarotid artery revascularization (tcar) procedure is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke. th

Complete history of Mr Ruedy stock trades at Silk Road Medical Inc

Silk Road Medical Inc executives and stock owners

Silk Road Medical Inc executives and other stock owners filed with the SEC include:

• Erica Rogers,
  President, Chief Executive Officer, Director
• Lucas Buchanan,
  Chief Financial Officer, Chief Operating Officer
• Andrew Davis,
  Executive Vice President - Global Sales and Marketing
• Lucas W. Buchanan,
  CFO & COO
• Andrew S. Davis,
  Chief Commercial Officer
• Erica J. Rogers,
  Pres, CEO & Director
• Richard M. Ruedy,
  Exec. VP of Clinical, Regulatory Affairs & Quality Assurance
• Jack Lasersohn,
  Independent Director
• Ruoxi Chen,
  Independent Director
• Donald Zurbay,
  Independent Director
• Elizabeth Weatherman,
  Independent Director
• Tony Chou,
  Independent Director
• Lynn Lewis,
  IR Contact Officer
• Rick Anderson,
  Director
• William Whealon,
  Executive Vice President - Research and Development
• Richard Ruedy,
  Executive Vice President - Regulatory Affairs, Clinical Affairs & Quality Assurance
• Dr. Sumaira MacDonald,
  Exec. Medical Director
• Alison Highlander,
  VP of HR
• Matthew McCarthy,
  VP of Marketing
• William Hill,
  Gen. Counsel
• Mhairi L. Jones,
  VP of Fin. & Accounting
• Kevin M Klemz,
  EVP/Chief Legal Officer/Sec.
• Pincus & Co.Warburg Pincus ...,
  
• John E Runnells,
  
• Richard B Emmitt,
  
• Pincus & Co.Kaye Charles R ...,
  
• Amr Kronfol,
  Director
• Group Lp Vertical,
  
• Venture Partners Xiii, Lp C...,
  
• X Finance, L.P.Wpx Gp, L.P....,
  
• Robert Mittendorff,
  Director
• Pincus & Co.Warburg Pincus ...,
  
• Kevin J. Ballinger,
  
• Tanisha Carino,
  
• Chas Mc Khann,
  Chief Executive Officer
• Marie L. Jones,
  VP, Finance and CAO